NovoCure NVCR
NASDAQ NVCR
$15.95 -0.04 (-0.25%)
At close: Sep 30, 2026 · 4:00 PM EDT

NovoCure (NVCR) Convertible Debt (2023 - 2024)

Updated

NovoCure (NVCR) recorded Convertible Debt of $556.51 million in Q2 2024.

Analysis

NovoCure (NVCR) Convertible Debt (2023 - 2024) Analysis & Trends

At the end of FY2023, NovoCure reported Convertible Debt of $568.82 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 NovoCure 1.86 Bn -491.82 Mn 142.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 556.51 Mn
Dec 31, 2023 568.82 Mn
API Access

NovoCure Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=NVCR&period=max&api_key=YOUR_API_KEY